*Department of Clinical Pathology and Genetics, Sahlgrenska University Hospital, Gothenburg
#Department of Clinical Genetics and Pathology, University and Regional Laboratories, Skåne University Hospital, Lund University
††Department of Clinical Genetics, Lund University, Lund, Sweden
†Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore
‡Research Department of Pathology, University College London Cancer Institute, London
§Department of Histopathology, Nottingham City Hospital, Nottingham
∥Department of Histopathology, Addenbrooke’s Hospital, Cambridge
¶Department of Histopathology, Heartlands Hospital, Birmingham
**Department of Musculoskeletal Pathology, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK
Conflicts of interest and source of funding: N.P. is funded through a Cancer Research UK Clinician Scientist fellowship. H.F. and F.P. are supported by grants from the Johan Jansson Foundation. F.M. is supported by grants from the Swedish Cancer Society (CAN2017/269) and Region Skåne. A.F. is an NIHR (UK) Senior Investigator. The remaining authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Florian Puls, MD, FRCPath, Department of Clinical Pathology and Genetics, Sahlgrenska University Hospital, Gothenburg 43146, Sweden (e-mail: [email protected]).
